CORMEDIX INC.

Lobbying for CORMEDIX INC. · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $150,000.00 expenses · posted Jul 31, 2025

Lobbying activity 1

Health Issues

H.R.____/S.____, Chronic Kidney Disease Improvement in Research and Treatment Act Issues related to patient access to infection prevention.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.